158 related articles for article (PubMed ID: 9524574)
1. Teratocarcinomas and human embryology: pluripotent human EC cell lines. Review article.
Andrews PW
APMIS; 1998 Jan; 106(1):158-67; discussion 167-8. PubMed ID: 9524574
[TBL] [Abstract][Full Text] [Related]
2. Human Wnt-13 is developmentally regulated during the differentiation of NTERA-2 pluripotent human embryonal carcinoma cells.
Wakeman JA; Walsh J; Andrews PW
Oncogene; 1998 Jul; 17(2):179-86. PubMed ID: 9674702
[TBL] [Abstract][Full Text] [Related]
3. Testicular teratocarcinogenesis in mice--a review.
Matin A; Collin GB; Varnum DS; Nadeau JH
APMIS; 1998 Jan; 106(1):174-82. PubMed ID: 9524576
[TBL] [Abstract][Full Text] [Related]
4. Expression of Wnt and Notch pathway genes in a pluripotent human embryonal carcinoma cell line and embryonic stem cell.
Walsh J; Andrews PW
APMIS; 2003 Jan; 111(1):197-210; discussion 210-1. PubMed ID: 12760378
[TBL] [Abstract][Full Text] [Related]
5. The CDK inhibitor p27 enhances neural differentiation in pluripotent NTERA2 human EC cells, but does not permit differentiation of 2102Ep nullipotent human EC cells.
Bahrami AR; Matin MM; Andrews PW
Mech Dev; 2005 Sep; 122(9):1034-42. PubMed ID: 16023837
[TBL] [Abstract][Full Text] [Related]
6. Brachyury is expressed by human teratocarcinoma cells in the absence of mesodermal differentiation.
Gokhale PJ; Giesberts AM; Andrews PW
Cell Growth Differ; 2000 Mar; 11(3):157-62. PubMed ID: 10768863
[TBL] [Abstract][Full Text] [Related]
7. Expression of teratocarcinoma-derived growth factor-1 (TDGF-1) in testis germ cell tumors and its effects on growth and differentiation of embryonal carcinoma cell line NTERA2/D1.
Baldassarre G; Romano A; Armenante F; Rambaldi M; Paoletti I; Sandomenico C; Pepe S; Staibano S; Salvatore G; De Rosa G; Persico MG; Viglietto G
Oncogene; 1997 Aug; 15(8):927-36. PubMed ID: 9285688
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of proliferation and induction of differentiation of pluripotent human embryonal carcinoma cells by osteogenic protein-1 (or bone morphogenetic protein-7).
Andrews PW; Damjanov I; Berends J; Kumpf S; Zappavigna V; Mavilio F; Sampath K
Lab Invest; 1994 Aug; 71(2):243-51. PubMed ID: 7521445
[TBL] [Abstract][Full Text] [Related]
9. Hybrids of pluripotent and nullipotent human embryonal carcinoma cells: partial retention of a pluripotent phenotype.
Duran C; Talley PJ; Walsh J; Pigott C; Morton IE; Andrews PW
Int J Cancer; 2001 Aug; 93(3):324-32. PubMed ID: 11433395
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of human pluripotent teratocarcinoma stem cells induced by bone morphogenetic protein-2.
Pera MF; Herszfeld D
Reprod Fertil Dev; 1998; 10(7-8):551-5. PubMed ID: 10612460
[TBL] [Abstract][Full Text] [Related]
11. ID gene expression varies with lineage during differentiation of pluripotential male germ cell tumor cell lines.
Houldsworth J; Reuter VE; Bosl GJ; Chaganti RS
Cell Tissue Res; 2001 Mar; 303(3):371-9. PubMed ID: 11320653
[TBL] [Abstract][Full Text] [Related]
12. Cell cycle regulators in testicular cancer: loss of p18INK4C marks progression from carcinoma in situ to invasive germ cell tumours.
Bartkova J; Thullberg M; Rajpert-De Meyts E; Skakkebaek NE; Bartek J
Int J Cancer; 2000 Feb; 85(3):370-5. PubMed ID: 10652429
[TBL] [Abstract][Full Text] [Related]
13. Gene regulation during neuronal and non-neuronal differentiation of NTERA2 human teratocarcinoma-derived stem cells.
Ackerman SL; Knowles BB; Andrews PW
Brain Res Mol Brain Res; 1994 Aug; 25(1-2):157-62. PubMed ID: 7984043
[TBL] [Abstract][Full Text] [Related]
14. High-throughput microRNAome analysis in human germ cell tumours.
Gillis AJ; Stoop HJ; Hersmus R; Oosterhuis JW; Sun Y; Chen C; Guenther S; Sherlock J; Veltman I; Baeten J; van der Spek PJ; de Alarcon P; Looijenga LH
J Pathol; 2007 Nov; 213(3):319-28. PubMed ID: 17893849
[TBL] [Abstract][Full Text] [Related]
15. A cloned human germ cell tumor-derived cell line differentiating in culture.
Tienari J; Reima I; Larramendy ML; Knuutila S; von Boguslawsky K; Kaartinen M; Virtanen I; Lehtonen E
Int J Cancer; 1998 Aug; 77(5):710-9. PubMed ID: 9688304
[TBL] [Abstract][Full Text] [Related]
16. Genetics and biology of adult human male germ cell tumors.
Chaganti RS; Houldsworth J
Cancer Res; 2000 Mar; 60(6):1475-82. PubMed ID: 10749107
[TBL] [Abstract][Full Text] [Related]
17. Human teratocarcinomas.
Andrews PW
Biochim Biophys Acta; 1988 Aug; 948(1):17-36. PubMed ID: 3293662
[TBL] [Abstract][Full Text] [Related]
18. Lysine methylation represses p53 activity in teratocarcinoma cancer cells.
Zhu J; Dou Z; Sammons MA; Levine AJ; Berger SL
Proc Natl Acad Sci U S A; 2016 Aug; 113(35):9822-7. PubMed ID: 27535933
[TBL] [Abstract][Full Text] [Related]
19. Self-renewal of teratocarcinoma and embryonic stem cells.
Chambers I; Smith A
Oncogene; 2004 Sep; 23(43):7150-60. PubMed ID: 15378075
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD30 and CD30 ligand in cultured cell lines from human germ-cell tumors.
Pera MF; Bennett W; Cerretti DP
Lab Invest; 1997 Apr; 76(4):497-504. PubMed ID: 9111512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
